To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene RAB13andJTBTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
565 supporting clones for gene RAB13andJTB back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BP374714 umbilical cord .a 1 to 586 1 to 586   tiling clone,   586/586
(100 %)
2 diff
(99.7 %id)
BJ997167.
matches multiple genes
hepatoblastoma .a 2 to 447 1 to 446     also hits gene karflee 446/446
(100 %)
1 diff
(99.8 %id)
CB148747 Liver .a 2 to 185 1 to 184       184/184
(100 %)
0 diff
(100 %id)
BM504028 Pancreas, Purified pancreatic islet .a 8 to 643 6 to 641       636/641
(99 %)
6 diff
(99.1 %id)
BX283427 amelanotic melanoma, cell line, skin .a 17 to 502 1 to 488       488/490
(99 %)
4 diff
(99.2 %id)
BM555992 amelanotic melanoma, cell line, skin .a 18 to 904 1 to 884 K153X AAA   884/885
(99 %)
16 diff
(98.2 %id)
BC094846 Skin, melanoma, amelanotic .a 18 to 906 1 to 889 exact AAA   889/889
(100 %)
0 diff
(100 %id)
BM423438 amelanotic melanoma, cell line, skin .a 18 to 904 1 to 897 exact     897/1069
(83 %)
18 diff
(98.4 %id)
X75593   .a 27 to 1199 24 to 1198 exact tiling clone, AAA   1175/1198
(98 %)
7 diff
(99.5 %id)
BM819755 stomach .a 31 to 616 1 to 584       584/584
(100 %)
3 diff
(99.5 %id)
DA584520 lung .a 32 to 602 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
CX164006 human embryonic stem cells differentiated toan early endodermal cell type .a 33 to 821 1 to 789 exact     789/789
(100 %)
0 diff
(100 %id)
BM819881 stomach .a 33 to 338 1 to 306       306/306
(100 %)
0 diff
(100 %id)
CD245623 White Matter .a 34 to 685 31 to 683       653/943
(69 %)
13 diff
(98.7 %id)
BP244433 Kidney .a 35 to 618 1 to 584       584/584
(100 %)
0 diff
(100 %id)
DA611448   .a 35 to 527 2 to 494   capped   493/493
(100 %)
1 diff
(99.8 %id)
CN396072 embryonic stem cells, cell lines H1, H7, andH9 .a 37 to 664 1 to 628       628/628
(100 %)
0 diff
(100 %id)
CF126823 Chondrosarcoma Lung Metastasis cell lines, lung .a 38 to 531 1 to 494       494/494
(100 %)
0 diff
(100 %id)
BP336815 coronary artery .a 38 to 629 1 to 592       592/592
(100 %)
1 diff
(99.9 %id)
TI_154189884   .a 38 to 849 51 to 852 K138X D159G E160*     802/917
(87 %)
18 diff
(98.1 %id)
DA889785   .a 39 to 606 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA811913 ovary, tumor tissue .a 40 to 578 54 to 592   capped   539/591
(91 %)
6 diff
(99.0 %id)
BM820241 stomach .a 40 to 515 1 to 476       476/476
(100 %)
0 diff
(100 %id)
CR612138 Neuroblastoma Cot 10-normalized .a 41 to 1165 1 to 1125 exact     1125/1125
(100 %)
0 diff
(100 %id)
CF128616 Chondrosarcoma Lung Metastasis cell lines, lung .a 42 to 820 1 to 774 N196T T197P N198T K199S C200A ...     774/774
(100 %)
5 diff
(99.4 %id)
TI_154194732   .a 42 to 908 51 to 907 N196T T197P N198T K199S C200A ...     857/1028
(83 %)
16 diff
(98.5 %id)
AA970570 Kidney, kidney tumor .a 44 to 458 1 to 415     Submitted on the opposite strand 415/415
(100 %)
0 diff
(100 %id)
CN396070 embryonic stem cells, DMSO-treated H9 cellline .a 46 to 662 1 to 617       617/617
(100 %)
5 diff
(99.2 %id)
BM473489 melanotic melanoma, skin .a 48 to 807 10 to 774 G174R P185S K194Q N198T K199Q ...     765/1192
(64 %)
26 diff
(97.9 %id)
BC000799 Placenta, choriocarcinoma .a 49 to 1199 1 to 1151 exact available from MGC, AAA   1151/1151
(100 %)
0 diff
(100 %id)
CA390447 eye, RPE/choroid .a 49 to 451 1 to 403       403/403
(100 %)
0 diff
(100 %id)
CX871351 embryonic stem .a 49 to 791 1 to 743 exact     743/743
(100 %)
0 diff
(100 %id)
NM_002870.2   .a 49 to 1199 1 to 1151 exact RefSeq, AAA   1151/1151
(100 %)
0 diff
(100 %id)
DR006317 Prostate .a 52 to 626 1 to 575       575/575
(100 %)
5 diff
(99.2 %id)
CN396071 embryonic stem cells, DMSO-treated H9 cellline .a 53 to 533 1 to 481       481/481
(100 %)
1 diff
(99.8 %id)
CN396076 embryonic stem cells, DMSO-treated H9 cellline .a 53 to 796 1 to 745 exact     745/745
(100 %)
1 diff
(99.9 %id)
CN396080 embryonic stem cells, cell lines H1, H7, andH9 .a 54 to 797 1 to 745 exact     745/745
(100 %)
3 diff
(99.6 %id)
CB110001 Liver .a 57 to 518 1 to 462       462/462
(100 %)
1 diff
(99.8 %id)
CB113473 Liver .a 57 to 214 1 to 158       158/158
(100 %)
1 diff
(99.4 %id)
CB113894 Liver .a 57 to 524 1 to 468       468/468
(100 %)
1 diff
(99.8 %id)
CB113903 Liver .a 57 to 639 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
CB113968 Liver .a 57 to 660 1 to 604       604/604
(100 %)
1 diff
(99.9 %id)
CB114014 Liver .a 57 to 491 1 to 435       435/435
(100 %)
1 diff
(99.8 %id)
CB114063 Liver .a 57 to 294 1 to 238       238/238
(100 %)
1 diff
(99.6 %id)
CB114114 Liver .a 57 to 620 1 to 564       564/564
(100 %)
2 diff
(99.7 %id)
CB114131 Liver .a 57 to 661 1 to 605       605/605
(100 %)
1 diff
(99.9 %id)
CB114207 Liver .a 57 to 620 1 to 564       564/564
(100 %)
1 diff
(99.9 %id)
CB115287 Liver .a 57 to 620 1 to 564       564/564
(100 %)
1 diff
(99.9 %id)
CB118253 Liver .a 57 to 658 1 to 602       602/602
(100 %)
2 diff
(99.7 %id)
CB119091 Liver .a 57 to 342 1 to 286       286/286
(100 %)
2 diff
(99.4 %id)
CB119229 Liver .a 57 to 620 1 to 564       564/564
(100 %)
1 diff
(99.9 %id)
CB119278 Liver .a 57 to 517 1 to 461       461/461
(100 %)
1 diff
(99.8 %id)
CB121331 Liver .a 57 to 660 1 to 604       604/604
(100 %)
2 diff
(99.7 %id)
CB121333 Liver .a 57 to 524 1 to 468       468/468
(100 %)
1 diff
(99.8 %id)
CB121387 Liver .a 57 to 514 1 to 458       458/458
(100 %)
1 diff
(99.8 %id)
CN396069 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 59 to 696 1 to 638       638/638
(100 %)
1 diff
(99.9 %id)
BM728232 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 60 to 521 1 to 460   fully sequenced,   460/460
(100 %)
2 diff
(99.6 %id)
CB158668 Liver .a 62 to 530 1 to 469       469/469
(100 %)
0 diff
(100 %id)
BG282116 melanotic melanoma, skin .a 66 to 778 1 to 713 S173V G174R G175R R176P R177E ...     713/714
(99 %)
3 diff
(99.6 %id)
CB143317 Liver .a 66 to 524 1 to 459       459/459
(100 %)
0 diff
(100 %id)
CB149161 Liver .a 66 to 660 1 to 595       595/595
(100 %)
0 diff
(100 %id)
BG169213 hypernephroma, cell line, Kidney .a 69 to 769 1 to 697 S186V T187L D188T L189*     697/941
(74 %)
10 diff
(99.0 %id)
CN396074 embryonic stem cells, cell lines H1, H7, andH9 .a 71 to 729 1 to 659       659/659
(100 %)
3 diff
(99.6 %id)
BM831782 stomach .a 71 to 365 1 to 295       295/295
(100 %)
0 diff
(100 %id)
BG333127 large cell carcinoma, lung .a 73 to 745 1 to 672       672/674
(99 %)
3 diff
(99.6 %id)
AA375193 lung .a 74 to 189 1 to 116       116/116
(100 %)
0 diff
(100 %id)
CB113485 Liver .a 77 to 238 1 to 162       162/162
(100 %)
1 diff
(99.4 %id)
BP347742 brain .a 79 to 659 1 to 581       581/581
(100 %)
3 diff
(99.5 %id)
CB128367 Liver .a 82 to 562 1 to 481       481/481
(100 %)
0 diff
(100 %id)
AK291580 placenta .a 83 to 1236 1 to 1154 exact     1154/1154
(100 %)
1 diff
(100.0 %id)
DA840603 placenta .a 84 to 626 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
BE047730 brain, tumor, 5 pooled (see description) .a 87 to 537 1 to 451   fully sequenced,   451/451
(100 %)
0 diff
(100 %id)
AW083784 colon, moderately differentiated adenocarcinoma .a 87 to 580 17 to 510     Submitted on the opposite strand 494/494
(100 %)
1 diff
(99.8 %id)
BX101038 melanocyte .a 92 to 842 1 to 751 A161V     751/755
(99 %)
2 diff
(99.8 %id)
N31889 melanocyte .a 95 to 610 1 to 514       514/515
(99 %)
4 diff
(99.3 %id)
BP249738 Kidney .a 96 to 677 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP260784 small intestine .a 97 to 677 1 to 581       581/582
(99 %)
3 diff
(99.5 %id)
BP261186 small intestine .a 97 to 677 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
BC073168 Peripheral Nervous System, sympathetictrunk .a 98 to 1199 1 to 1102 exact available from MGC, AAA   1102/1102
(100 %)
0 diff
(100 %id)
BF970305 adrenal cortex carcinoma, cell line, adrenal gland .a 98 to 699 1 to 602       602/602
(100 %)
0 diff
(100 %id)
BQ722522 sympathetic trunk .a 99 to 1053 1 to 958 exact     958/958
(100 %)
32 diff
(96.7 %id)
CB159728 Liver .a 104 to 620 1 to 517       517/517
(100 %)
0 diff
(100 %id)
AL519821.
matches multiple genes
brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 106 to 1165 1050 to 1 A2K K3P A4X Y5A D6T ...   also hits gene karflee 1050/1051
(99 %)
16 diff
(98.5 %id)
BG749873 eye, normal pigmented retinal epithelium .a 109 to 830 1 to 720 exact     720/721
(99 %)
4 diff
(99.5 %id)
BM820827 stomach .a 117 to 458 1 to 342       342/342
(100 %)
1 diff
(99.8 %id)
CR614708 Placenta Cot 25-normalized .a 120 to 1202 1 to 1083 exact     1083/1083
(100 %)
0 diff
(100 %id)
CN396068 embryonic stem cells, cell lines H1, H7, andH9 .a 123 to 750 1 to 629       629/629
(100 %)
1 diff
(99.9 %id)
CN396081 embryonic stem cells, cell lines H1, H7, andH9 .a 123 to 660 1 to 538       538/538
(100 %)
0 diff
(100 %id)
CN396082 embryonic stem cells, DMSO-treated H9 cellline .a 124 to 462 1 to 339       339/339
(100 %)
0 diff
(100 %id)
AL544798 placenta, Placenta Cot 25-normalized .a 131 to 1202 1 to 1071 exact fully sequenced,   1071/1071
(100 %)
6 diff
(99.5 %id)
CA307076 Alveolar Macrophage, lung .a 131 to 880 768 to 19 exact AAA   750/759
(98 %)
0 diff
(100 %id)
BP341146 stomach mucosa .a 133 to 713 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BF342331 brain, glioblastoma with EGFR amplification .a 140 to 878 1 to 752 D6G H7P L8P F9L K10Q ...     752/870
(86 %)
17 diff
(98.1 %id)
BG676049 skin, squamous cell carcinoma .a 140 to 916 1 to 781 exact     781/824
(94 %)
14 diff
(98.4 %id)
AY423722   .a 142 to 771 1 to 630 exact     630/630
(100 %)
0 diff
(100 %id)
TI_1948099829   .a 142 to 497 125 to 480   fully sequenced,   356/382
(93 %)
6 diff
(98.5 %id)
AF498948 brain .a 143 to 754 1 to 612 exact     612/612
(100 %)
0 diff
(100 %id)
BT019700   .a 143 to 752 1 to 610       610/612
(99 %)
1 diff
(99.9 %id)
BT019701   .a 143 to 752 1 to 610       610/612
(99 %)
1 diff
(99.9 %id)
CV024436 mixed .a 143 to 754 1 to 611 N180X N198X K199Q     611/658
(92 %)
3 diff
(99.6 %id)
BG678949 skin, squamous cell carcinoma .a 146 to 1067 1 to 928       928/960
(96 %)
24 diff
(97.5 %id)
DA523916 brain .a 149 to 704 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
BU501356 eye, normal pigmented retinal epithelium .a 150 to 899 1 to 751       751/769
(97 %)
3 diff
(99.7 %id)
BU526711 epidermoid carcinoma, cell line, lung .a 157 to 904 38 to 783   AAA   746/783
(95 %)
9 diff
(98.9 %id)
BQ719615 sympathetic trunk .a 162 to 1053 1 to 900       900/900
(100 %)
15 diff
(98.4 %id)
BU956661 adenocarcinoma, cell line, breast .a 163 to 978 1 to 821       821/866
(94 %)
14 diff
(98.4 %id)
BE884387 leiomyosarcoma, uterus .a 165 to 858 1 to 703       703/843
(83 %)
13 diff
(98.5 %id)
BF973721 leiomyosarcoma cell line, uterus .a 165 to 823 1 to 661       661/661
(100 %)
9 diff
(98.7 %id)
CN396075 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 166 to 727 1 to 564       564/564
(100 %)
2 diff
(99.7 %id)
BC009227 Ovary, adenocarcinoma .a 166 to 1199 1 to 1034   available from MGC, AAA   1034/1034
(100 %)
0 diff
(100 %id)
CN396083 embryonic stem cells, cell lines H1, H7, andH9 .a 172 to 797 1 to 625       625/625
(100 %)
1 diff
(99.9 %id)
BE294006 muscle, rhabdomyosarcoma .a 172 to 788 1 to 614       614/614
(100 %)
3 diff
(99.6 %id)
BE898887 adenocarcinoma cell line, ovary .a 185 to 841 1 to 657       657/657
(100 %)
0 diff
(100 %id)
CF126279 Chondrosarcoma Lung Metastasis cell lines, lung .a 185 to 856 4 to 675       672/675
(99 %)
2 diff
(99.8 %id)
TI_154189244   .a 185 to 1171 54 to 1037       984/1070
(91 %)
36 diff
(96.7 %id)
CA430950 cell lines, Chondrosarcoma .a 190 to 909 720 to 1       720/720
(100 %)
0 diff
(100 %id)
BG250366 adenocarcinoma, cell line, Liver .a 193 to 884 1 to 697       697/709
(98 %)
12 diff
(98.4 %id)
TI_149282373   .a 194 to 911 801 to 85   AAA   717/1150
(62 %)
8 diff
(99.4 %id)
BU934260 mixed (pool of 40 RNAs) .a 214 to 916 1 to 712       712/821
(86 %)
15 diff
(98.2 %id)
BU623421 cell lines, Enchondroma .a 216 to 904 707 to 19   AAA   689/689
(100 %)
1 diff
(99.9 %id)
AU123205   .a 240 to 832 2 to 594   capped   593/593
(100 %)
3 diff
(99.5 %id)
BF476170 Kidney .a 250 to 911 663 to 1       663/667
(99 %)
2 diff
(99.8 %id)
BG285591 bladder, transitional cell papilloma, cell line .a 264 to 974 1 to 716       716/822
(87 %)
24 diff
(97.1 %id)
BP332459 renal proximal tubule .a 275 to 856 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
AW470103 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 281 to 914 634 to 1       634/634
(100 %)
1 diff
(99.9 %id)
CU454184 epidermis .a 293 to 1058 776 to 11     Submitted on the opposite strand 766/776
(98 %)
1 diff
(99.9 %id)
AL570891 placenta, Placenta Cot 25-normalized .a 297 to 1128 838 to 6   fully sequenced,   833/838
(99 %)
1 diff
(99.9 %id)
BI857778 breast, mammary adenocarcinoma, cell line .a 301 to 1118 15 to 854       758/864
(87 %)
31 diff
(96.5 %id)
TI_57191041   .a 301 to 1118 71 to 910       758/864
(87 %)
31 diff
(96.5 %id)
CA503023 Human Lung Epithelial cells, lung .a 303 to 906 620 to 17   AAA   604/604
(100 %)
4 diff
(99.4 %id)
AI431853 Kidney .a 305 to 907 603 to 1       603/603
(100 %)
0 diff
(100 %id)
CF126708 Chondrosarcoma Lung Metastasis cell lines, lung .a 325 to 1019 1 to 693       693/693
(100 %)
1 diff
(99.9 %id)
TI_154189746   .a 325 to 1197 50 to 920       871/875
(99 %)
17 diff
(98.1 %id)
TI_149290770   .a 328 to 1199 947 to 88   AAA   860/985
(87 %)
21 diff
(97.9 %id)
BM994437 lung, Metastatic Chondrosarcoma .a 350 to 882 549 to 17   AAA   533/533
(100 %)
2 diff
(99.7 %id)
BM983801 lung, Primary Lung Epithelial Cells .a 352 to 911 578 to 19   AAA   560/560
(100 %)
1 diff
(99.9 %id)
CN396078 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 360 to 897 1 to 538       538/538
(100 %)
0 diff
(100 %id)
BU630643 cell lines, Chondrosarcoma .a 377 to 882 522 to 17   AAA   506/506
(100 %)
1 diff
(99.9 %id)
BQ221756 large cell carcinoma, lung .a 378 to 1200 1 to 823   AAA   823/823
(100 %)
6 diff
(99.3 %id)
BQ652220 hepatocellular carcinoma, cell line, Liver .a 382 to 1199 1 to 830   AAA   830/830
(100 %)
18 diff
(97.9 %id)
BU587661 mixed (pool of 40 RNAs) .a 412 to 884 1 to 473       473/477
(99 %)
4 diff
(99.2 %id)
CA424047 cell lines, Chondrosarcoma .a 416 to 1199 798 to 17   AAA   782/782
(100 %)
4 diff
(99.5 %id)
BQ934342 sciatic nerve .a 424 to 1197 1 to 780       780/966
(80 %)
11 diff
(98.9 %id)
BG150437 pooled germ cell tumors .a 432 to 898 467 to 1       467/467
(100 %)
1 diff
(99.8 %id)
TI_154126518   .a 433 to 1199 862 to 100   AAA   763/920
(82 %)
8 diff
(99.2 %id)
BM989645 lung, Metastatic Chondrosarcoma .a 435 to 1203 780 to 15   tiling clone, AAA   766/770
(99 %)
2 diff
(99.8 %id)
TI_1948099830   .a 436 to 767 445 to 115   fully sequenced,   331/445
(74 %)
2 diff
(99.6 %id)
CB054521 brain, glioblastoma (pooled) .a 441 to 1083 1 to 643       643/643
(100 %)
8 diff
(98.8 %id)
DB067205 testis .a 449 to 980 2 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
BE877880 large cell carcinoma, undifferentiated, lung .a 460 to 1197 1 to 728   AAA   728/728
(100 %)
13 diff
(98.3 %id)
BQ671007 epidermoid carcinoma, cell line, salivary gland .a 465 to 1200 1 to 737   AAA   737/737
(100 %)
12 diff
(98.4 %id)
TI_154126285   .a 466 to 1202 841 to 109       733/1028
(71 %)
10 diff
(99.1 %id)
TI_159690003   .a 468 to 1199 844 to 115   AAA   730/1018
(71 %)
43 diff
(95.8 %id)
AI906861.
matches multiple genes
breast .a 489 to 953 472 to 8     also hits gene karflee 465/495
(93 %)
0 diff
(100 %id)
AI906871 breast .a 489 to 926 470 to 33       438/481
(91 %)
0 diff
(100 %id)
CA416627 Chondrosarcoma Cell line .a 491 to 1199 725 to 17   AAA   709/709
(100 %)
0 diff
(100 %id)
BU619245 Cell Line, Chondrosarcoma .a 497 to 1199 719 to 17   AAA   703/703
(100 %)
0 diff
(100 %id)
BM679890 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 499 to 1203 719 to 15   fully sequenced, AAA   705/705
(100 %)
2 diff
(99.8 %id)
BF843625 head_neck .a 503 to 849 355 to 7     Submitted on the opposite strand 349/400
(87 %)
2 diff
(99.5 %id)
TI_154091050   .a 505 to 1199 786 to 93   AAA   694/885
(78 %)
8 diff
(99.1 %id)
CD368021 Alveolar Macrophage, lung .a 505 to 1199 711 to 17   AAA   695/695
(100 %)
2 diff
(99.8 %id)
BE894370 melanotic melanoma, skin .a 506 to 1199 1 to 696   AAA   696/696
(100 %)
3 diff
(99.6 %id)
BI856551 breast, mammary adenocarcinoma, cell line .a 506 to 913 1 to 409   AAA   409/409
(100 %)
4 diff
(99.1 %id)
TI_57188497   .a 506 to 913 57 to 465   AAA   409/409
(100 %)
4 diff
(99.1 %id)
AI863483 brain, tumor, 5 pooled (see description) .a 507 to 904 398 to 1   fully sequenced,   398/398
(100 %)
0 diff
(100 %id)
CF129697 Chondrosarcoma Lung Metastasis cell lines, lung .a 517 to 1168 1 to 652       652/652
(100 %)
0 diff
(100 %id)
TI_154191452   .a 517 to 1200 50 to 733       684/997
(68 %)
1 diff
(99.9 %id)
BQ956463 epidermoid carcinoma, cell line, lung .a 523 to 1197 675 to 1     Submitted on the opposite strand 675/899
(75 %)
0 diff
(100 %id)
BM997537 lung, Metastatic Chondrosarcoma .a 526 to 1199 690 to 17   AAA   674/674
(100 %)
0 diff
(100 %id)
BU681833 lung .a 529 to 1199 687 to 17   AAA   671/671
(100 %)
1 diff
(99.9 %id)
CA421664 Bone, Enchondroma cell line .a 529 to 1197 687 to 19   AAA   669/669
(100 %)
1 diff
(99.9 %id)
AA169674   .a 530 to 880 1 to 352   fully sequenced,   352/352
(100 %)
1 diff
(99.8 %id)
CA416461 Chondrosarcoma Cell line .a 533 to 1199 685 to 19   AAA   667/670
(99 %)
3 diff
(99.6 %id)
AA436912   .a 535 to 1034 1 to 500       500/500
(100 %)
2 diff
(99.6 %id)
BM990183 lung, Metastatic Chondrosarcoma .a 544 to 1203 674 to 15   AAA   660/660
(100 %)
0 diff
(100 %id)
T20239   .a 546 to 835 290 to 1       290/293
(98 %)
11 diff
(96.3 %id)
AW015781   .a 554 to 882 346 to 18   AAA   329/329
(100 %)
1 diff
(99.7 %id)
AW001549 colon, colonic mucosa from 3 patients with Crohn'sdisease .a 557 to 1201 646 to 1       646/646
(100 %)
4 diff
(99.4 %id)
AW385448 leiomios .a 561 to 971 426 to 14       413/439
(94 %)
1 diff
(99.8 %id)
AI418763 Prostate .a 562 to 927 366 to 1       366/368
(99 %)
1 diff
(99.8 %id)
AW024567 Kidney .a 570 to 1199 631 to 1       631/632
(99 %)
1 diff
(99.9 %id)
AI752876 bone marrow stroma .a 576 to 911 355 to 19   AAA   337/337
(100 %)
1 diff
(99.8 %id)
CA434287 lung, Metastatic Chondrosarcoma .a 605 to 1199 611 to 17   AAA   595/595
(100 %)
0 diff
(100 %id)
AW514332 lung, two pooled squamous cell carcinomas .a 626 to 1203 584 to 8       577/587
(98 %)
3 diff
(99.5 %id)
BF437018 Prostate .a 638 to 1199 562 to 1       562/562
(100 %)
1 diff
(99.9 %id)
AI925851 adenocarcinoma, Pancreas .a 667 to 1199 551 to 18   AAA   534/536
(99 %)
2 diff
(99.7 %id)
C00883   .a 672 to 889 1 to 218       218/218
(100 %)
0 diff
(100 %id)
AW270033 lung, two pooled squamous cell carcinomas .a 683 to 1202 524 to 5       520/524
(99 %)
0 diff
(100 %id)
BM746183 stomach .a 696 to 880 1 to 186   AAA   186/186
(100 %)
1 diff
(99.5 %id)
BQ305248 breast .a 697 to 944 265 to 16       250/265
(94 %)
0 diff
(100 %id)
AA026499 heart .a 709 to 898 1 to 190   fully sequenced,   190/190
(100 %)
0 diff
(100 %id)
TI_149279720   .a 732 to 1199 530 to 64   AAA   467/1147
(40 %)
1 diff
(100.0 %id)
BG109029 Bone, osteosarcoma, cell line .a 733 to 1199 1 to 466   AAA   466/466
(100 %)
2 diff
(99.6 %id)
BI850384 Bone, osteosarcoma, cell line .a 733 to 1199 1 to 467       467/467
(100 %)
0 diff
(100 %id)
D82203   .a 737 to 1199 479 to 15       465/479
(97 %)
0 diff
(100 %id)
AA903153 leiomyosarcoma, soft tissue .a 784 to 1203 429 to 11   AAA   419/419
(100 %)
1 diff
(99.8 %id)
EC546228 Prostate .a 785 to 877 110 to 20       91/110
(82 %)
0 diff
(100 %id)
TI_149273394   .a 788 to 1199 497 to 86   AAA   412/988
(41 %)
3 diff
(99.7 %id)
AW086303 pooled .a 789 to 873 1 to 85     Submitted on the opposite strand 85/85
(100 %)
9 diff
(89.5 %id)
N23988 melanocyte .a 795 to 1202 411 to 4       408/411
(99 %)
0 diff
(100 %id)
AI340884 adenocarcinoma, breast .a 797 to 912 1 to 116     Submitted on the opposite strand 116/116
(100 %)
13 diff
(88.8 %id)
AI583856 bone marrow, CD34+, T negative, patient with chronicmyelogenous leukemia .a 797 to 892 1 to 96   AAA Submitted on the opposite strand 96/96
(100 %)
5 diff
(94.8 %id)
BU675781 lung, Primary Lung Epithelial Cells .a 799 to 1199 417 to 17   AAA   401/405
(99 %)
0 diff
(100 %id)
T24433   .a 804 to 881 80 to 3       78/80
(97 %)
0 diff
(100 %id)
CR610750 Placenta Cot 25-normalized .a 804 to 1202 1 to 399       399/399
(100 %)
0 diff
(100 %id)
AI571667 adenocarcinoma, Pancreas .a 809 to 1202 394 to 1       394/394
(100 %)
0 diff
(100 %id)
AI002301 Kidney, kidney tumor .a 815 to 1199 385 to 1       385/385
(100 %)
0 diff
(100 %id)
AA304238 aorta .a 830 to 1027 1 to 198       198/198
(100 %)
1 diff
(99.5 %id)
EC579299 Prostate .a 836 to 908 18 to 90       73/90
(81 %)
6 diff
(93.4 %id)
AI886027 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 836 to 1199 378 to 15   AAA   364/364
(100 %)
1 diff
(99.8 %id)
AA169486   .a 850 to 1199 359 to 11   fully sequenced, AAA   349/349
(100 %)
1 diff
(99.8 %id)
AA885743 metastatic prostate bone lesion .a 858 to 1199 342 to 1       342/349
(97 %)
1 diff
(99.8 %id)
AI304472 adenocarcinoma, colon .a 865 to 1199 353 to 19   AAA   335/335
(100 %)
3 diff
(99.2 %id)
AA026422 heart .a 868 to 1200 335 to 1   fully sequenced,   335/335
(100 %)
3 diff
(99.2 %id)
AI571593 adenocarcinoma, Pancreas .a 896 to 1202 307 to 1       307/307
(100 %)
2 diff
(99.4 %id)
BP337292 coronary artery .a 906 to 1199 1 to 294   AAA   294/294
(100 %)
1 diff
(99.7 %id)
BF931310 nervous_tumor .a 917 to 1145 230 to 2     Submitted on the opposite strand 229/263
(87 %)
0 diff
(100 %id)
AI081387 senescent fibroblast .a 924 to 1199 291 to 16   AAA   276/276
(100 %)
0 diff
(100 %id)
CN338442 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 930 to 1196 1 to 267       267/267
(100 %)
0 diff
(100 %id)
AW949448   .a 935 to 1197 264 to 2     Submitted on the opposite strand 263/442
(59 %)
0 diff
(100 %id)
AA948289 pooled germ cell tumors .a 946 to 1199 275 to 22   AAA   254/254
(100 %)
1 diff
(99.7 %id)
BE890968 melanotic melanoma, skin .a 955 to 1194 1 to 240       240/240
(100 %)
0 diff
(100 %id)
AA864372.
matches multiple genes
pooled germ cell tumors .a 962 to 1202 243 to 3     also hits gene karflee 241/243
(99 %)
0 diff
(100 %id)
T28211 colon, embryo .a 969 to 1199 268 to 38   AAA Submitted on the opposite strand 231/231
(100 %)
0 diff
(100 %id)
CB410383 maxilla, pooled .a 1003 to 1203 1 to 201   AAA   201/201
(100 %)
0 diff
(100 %id)
CD104801 Pooled-Skin .a 1010 to 1200 1 to 191   AAA   191/191
(100 %)
1 diff
(99.5 %id)
AI924283 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 1011 to 1200 190 to 1       190/190
(100 %)
1 diff
(99.5 %id)
AA525402 ovary .a 1017 to 1202 188 to 3       186/196
(94 %)
0 diff
(100 %id)
AW466332   .a 1043 to 1186 144 to 1       144/144
(100 %)
0 diff
(100 %id)
D45706 lung .a 1089 to 1202 1 to 114     Submitted on the opposite strand 114/114
(100 %)
0 diff
(100 %id)
AW470462.
matches multiple genes
ovary, papillary serous carcinoma .a 1127 to 1191 1 to 65     Submitted on the opposite strand, also hits gene karflee 65/65
(100 %)
3 diff
(95.4 %id)
BF718470.
matches multiple genes
epidermis, skin .a 1138 to 1197 60 to 1     also hits gene karflee 60/60
(100 %)
0 diff
(100 %id)
BE391153 endometrium, adenocarcinoma cell line, uterus .b 1 to 517 1 to 517   tiling clone,   517/517
(100 %)
1 diff
(99.9 %id)
TI_57166237   .b 1 to 762 19 to 779 Y2R tiling clone,   761/780
(97 %)
8 diff
(99.0 %id)
BE898360 adenocarcinoma cell line, ovary .b 3 to 440 1 to 435       435/435
(100 %)
3 diff
(99.4 %id)
BI835067 pooled pancreas and spleen .b 12 to 762 1 to 750       750/751
(99 %)
2 diff
(99.8 %id)
TI_1948099657.
matches multiple genes
  .b 160 to 618 572 to 115     also hits gene karflee 458/473
(96 %)
0 diff
(100 %id)
BG315308   .b 165 to 522 357 to 1       357/357
(100 %)
1 diff
(99.8 %id)
TI_1948100009.
matches multiple genes
  .b 166 to 618 565 to 114     also hits gene karflee 452/466
(96 %)
0 diff
(100 %id)
BG315450   .b 174 to 534 456 to 96       361/456
(79 %)
9 diff
(98.1 %id)
BG315072   .b 188 to 416 1 to 230       230/230
(100 %)
1 diff
(99.6 %id)
CB116370 Liver .b 238 to 655 1 to 418       418/418
(100 %)
1 diff
(99.8 %id)
AI970419 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .b 291 to 516 226 to 1       226/226
(100 %)
1 diff
(99.6 %id)
TI_44350088   .b 672 to 1466 121 to 922       802/1154
(69 %)
31 diff
(97.4 %id)
BU527541 epidermoid carcinoma, cell line, lung .b 702 to 1516 12 to 826   tiling clone,   815/950
(85 %)
11 diff
(98.9 %id)
BE790802 lung, small cell carcinoma .b 708 to 1500 1 to 793       793/796
(99 %)
8 diff
(99.0 %id)
AW249112 lung, small cell carcinoma .b 994 to 1381 10 to 397       388/397
(97 %)
6 diff
(98.5 %id)
CA455123   .b 1000 to 1588 1 to 596       596/1031
(57 %)
25 diff
(97.6 %id)
TI_57242427   .b 1000 to 1818 34 to 852   tiling clone,   819/852
(96 %)
6 diff
(99.3 %id)
BI917137 brain .b 1003 to 1747 1 to 746   tiling clone,   746/816
(91 %)
5 diff
(99.4 %id)
CT001750 T-Lymphocytes .b 1099 to 1613 1 to 515   tiling clone,   515/517
(99 %)
1 diff
(99.9 %id)
BF515287   .b 1122 to 1275 171 to 18   AAA   154/154
(100 %)
7 diff
(95.5 %id)
DA350282 substantia nigra .c 1 to 522 2 to 523 exact tiling clone, capped   522/522
(100 %)
1 diff
(99.9 %id)
AA987541 carcinoid, lung .d 1 to 284 282 to 1       282/345
(81 %)
2 diff
(99.5 %id)
CK822494 Pancreas, Purified pancreatic islet .d 1 to 611 17 to 627   tiling clone,   611/627
(97 %)
0 diff
(100 %id)
BM932015 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 1 to 294 17 to 310   fully sequenced,   294/310
(94 %)
0 diff
(100 %id)
BM932127 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 1 to 294 17 to 310   fully sequenced,   294/310
(94 %)
0 diff
(100 %id)
BE221881 carcinoid, lung .d 18 to 284 266 to 1       266/299
(88 %)
21 diff
(93.0 %id)
BM685047 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 133 to 300 168 to 1   fully sequenced,   168/168
(100 %)
0 diff
(100 %id)
BM685130 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 133 to 300 168 to 1   fully sequenced,   168/168
(100 %)
0 diff
(100 %id)
BQ325812 colon_ins .d 494 to 816 1 to 324       324/324
(100 %)
15 diff
(95.4 %id)
BI834959 pooled pancreas and spleen .d 605 to 1399 1 to 785   tiling clone,   785/812
(96 %)
17 diff
(98.0 %id)
TI_57167118   .d 605 to 1399 31 to 815       785/842
(93 %)
17 diff
(98.0 %id)
BM916212 amelanotic melanoma, cell line, skin .d 1250 to 1997 23 to 774 L136P V139G R140P K141E Q142S ... tiling clone,   752/1130
(66 %)
26 diff
(97.7 %id)
BE395014 endometrium, adenocarcinoma cell line, uterus .d 1253 to 1735 1 to 494       494/583
(84 %)
17 diff
(97.1 %id)
BM008983 adenocarcinoma, Pancreas .d 1260 to 2060 1 to 801 V124C I125H I126H R127S Q128S ... tiling clone,   801/801
(100 %)
11 diff
(98.7 %id)
TI_59386707   .d 1261 to 2060 102 to 901 V124C I125H I126H R127S Q128S ...     800/800
(100 %)
10 diff
(98.8 %id)
BI521473 pooled pancreas and spleen .d 1263 to 1737 1 to 473   fully sequenced,   473/473
(100 %)
4 diff
(99.2 %id)
BE394970 endometrium, adenocarcinoma cell line, uterus .d 1269 to 1945 1 to 672 G13A R14A H15T L16S C17A ...     672/743
(90 %)
25 diff
(96.7 %id)
BI522275 pooled pancreas and spleen .d 1676 to 2060 391 to 8   tiling clone, fully sequenced,   384/391
(98 %)
0 diff
(100 %id)
NM_006694.3   .e 1 to 1574 1 to 1574 exact RefSeq,   1574/1574
(100 %)
0 diff
(100 %id)
BQ064310 lymph, lymphoma, cell line .e 258 to 1189 12 to 948 T77Q G78D Y79M V80* tiling clone,   937/1029
(91 %)
31 diff
(97.0 %id)
BQ059043 lymph, lymphoma, cell line .e 266 to 1189 1 to 928 G111R V114L C122W V124G R127P ...     928/1082
(85 %)
15 diff
(98.7 %id)
BQ061799 lymph, lymphoma, cell line .e 266 to 1010 1 to 751       751/1029
(72 %)
11 diff
(99.0 %id)
BQ062102 lymph, lymphoma, cell line .e 266 to 1235 1 to 982 K69X L118P I119D F120P A121R ...     982/1039
(94 %)
25 diff
(97.6 %id)
BQ063321 lymph, lymphoma, cell line .e 266 to 1177 1 to 916 K94X L118P I119D F120L A121S ...     916/1023
(89 %)
10 diff
(99.1 %id)
BQ066292 lymph, lymphoma, cell line .e 266 to 1059 1 to 794       794/1101
(72 %)
8 diff
(99.3 %id)
BQ066456 lymph, lymphoma, cell line .e 266 to 1189 1 to 935 T77H G78R Y79I V80C E81R ...     935/1005
(93 %)
22 diff
(97.9 %id)
BQ641915 lymph, lymphoma, cell line .e 266 to 1016 1 to 751       751/910
(82 %)
7 diff
(99.3 %id)
DT217339 brain .e 273 to 941 1 to 669       669/669
(100 %)
0 diff
(100 %id)
TI_57230244   .e 283 to 818 85 to 637       553/929
(59 %)
6 diff
(99.4 %id)
BC000499 Lung, small cell carcinoma .e 288 to 1331 10 to 1053 exact available from MGC, AAA   1044/1044
(100 %)
0 diff
(100 %id)
AB016488   .e 292 to 1331 1 to 1040 exact     1040/1040
(100 %)
0 diff
(100 %id)
BG746511 adenocarcinoma cell line, colon .e 292 to 1185 1 to 899 F54L V55W V56*     899/900
(99 %)
22 diff
(97.6 %id)
BQ433369 epithelioid carcinoma, Pancreas .e 293 to 1143 1 to 862       862/893
(96 %)
20 diff
(97.8 %id)
CR599832 Placenta Cot 25-normalized .e 298 to 1319 1 to 1022 exact     1022/1022
(100 %)
0 diff
(100 %id)
BQ955026 large cell carcinoma, lung .e 298 to 1147 1 to 850       850/853
(99 %)
7 diff
(99.2 %id)
AA313810 colon .e 303 to 576 1 to 274       274/274
(100 %)
0 diff
(100 %id)
AF115850   .e 303 to 1331 1 to 1029 exact     1029/1038
(99 %)
1 diff
(100.0 %id)
TI_57162668   .e 306 to 1026 23 to 743       721/743
(97 %)
7 diff
(99.1 %id)
BF220140 lung, small cell carcinoma .e 307 to 951 1 to 645       645/649
(99 %)
1 diff
(99.9 %id)
TI_44171575   .e 309 to 1222 82 to 997 Q29K T77P V116C A117G C122W ...     916/1002
(91 %)
24 diff
(97.7 %id)
TI_44346444   .e 309 to 938 83 to 712       630/712
(88 %)
5 diff
(99.3 %id)
CR613105 Neuroblastoma Cot 10-normalized .e 310 to 1317 1 to 1008 exact     1008/1008
(100 %)
0 diff
(100 %id)
DB482439 hippocampus .e 310 to 469 1 to 160       160/160
(100 %)
0 diff
(100 %id)
BF568333 epithelioid carcinoma cell line, Pancreas .e 310 to 958 1 to 648   fully sequenced,   648/648
(100 %)
1 diff
(99.9 %id)
DB496160 hypothalamus .e 312 to 469 1 to 158       158/158
(100 %)
0 diff
(100 %id)
BI549739 brain, hippocampus .e 313 to 1222 1 to 912 Q29K T77P V116C A117G C122W ...     912/917
(99 %)
22 diff
(97.7 %id)
BM043041 carcinoma, cell line, Prostate .e 317 to 1223 1 to 914 G9W L10P Q12P R14P H15P ...     910/931
(97 %)
44 diff
(95.3 %id)
BQ951169 large cell carcinoma, lung .e 318 to 1177 1 to 867 N91K E92*     867/910
(95 %)
27 diff
(97.1 %id)
BP275790 Kidney .e 318 to 899 1 to 582       582/582
(100 %)
0 diff
(100 %id)
CB108038 Liver .e 318 to 646 1 to 329       329/329
(100 %)
0 diff
(100 %id)
BM765477 stomach .e 318 to 1036 1 to 719       719/719
(100 %)
0 diff
(100 %id)
BU944604 adenocarcinoma, cell line, breast .e 319 to 1189 1 to 879 V114L I119N V124G Q128P A135V ...     879/927
(94 %)
21 diff
(97.8 %id)
AK312106 tongue .e 320 to 1164 1 to 846 exact     846/846
(100 %)
1 diff
(99.9 %id)
BQ672965 epidermoid carcinoma, cell line, salivary gland .e 320 to 1191 1 to 875 E110Q A135G L136S E137G V139G ...     875/877
(99 %)
7 diff
(99.3 %id)
BG742538 skin .e 321 to 1200 1 to 892 E81A K82E I83N T84H C85M ...     890/893
(99 %)
19 diff
(97.9 %id)
DA893878 skeletal muscle .e 321 to 808 2 to 489   capped   488/488
(100 %)
0 diff
(100 %id)
BC001363 Skin, melanotic melanoma. .e 322 to 1330 9 to 1017 exact available from MGC, AAA   1009/1009
(100 %)
1 diff
(100.0 %id)
ES312741 beard hair, skin .e 323 to 431 1 to 108       108/108
(100 %)
1 diff
(99.1 %id)
BM832093 stomach .e 324 to 777 1 to 454       454/454
(100 %)
0 diff
(100 %id)
BQ278525 adenocarcinoma, cell line, breast .e 326 to 1325 1 to 1010 V139G R140P K141E Q142T I143N ...     1010/1054
(95 %)
32 diff
(97.0 %id)
BQ949163 large cell carcinoma, lung .e 326 to 1141 1 to 828       828/909
(91 %)
21 diff
(97.7 %id)
CF130935 Chondrosarcoma Lung Metastasis cell lines, lung .e 326 to 1098 1 to 771       771/771
(100 %)
5 diff
(99.4 %id)
TI_154193383   .e 326 to 1330 51 to 1033 T77Q G78D Y79M V80*     983/1058
(92 %)
52 diff
(95.1 %id)
BG339574 leiomyosarcoma cell line, uterus .e 329 to 1205 1 to 878 C48W W49L L50V V51G E52G ...     878/887
(98 %)
31 diff
(96.6 %id)
BI259978 cervical carcinoma cell line, cervix .e 329 to 1223 1 to 905 W49L L50A V51G E52G E53R ...     903/905
(99 %)
33 diff
(96.4 %id)
TI_57146602   .e 329 to 994 28 to 692       665/693
(95 %)
13 diff
(98.2 %id)
TI_57152946   .e 329 to 1205 61 to 931 A3L K38N L39A S40V A41S ...     873/934
(93 %)
26 diff
(97.3 %id)
TI_57166290   .e 329 to 1119 30 to 818       789/830
(95 %)
21 diff
(97.5 %id)
CR603308 HeLa cells Cot 25-normalized .e 330 to 1297 1 to 968 exact     968/968
(100 %)
0 diff
(100 %id)
AL556916 placenta .e 330 to 958 1 to 629   fully sequenced,   629/629
(100 %)
0 diff
(100 %id)
BM473477 duodenal adenocarcinoma, cell line, small intestine .e 332 to 1293 1 to 974 P72X E73*     974/1081
(90 %)
33 diff
(97.0 %id)
BP423104 small intestine .e 333 to 844 1 to 512     Submitted on the opposite strand 512/512
(100 %)
0 diff
(100 %id)
DB504759 hypothalamus .e 334 to 469 1 to 136       136/136
(100 %)
0 diff
(100 %id)
BU196184 melanotic melanoma, cell line, skin .e 335 to 1218 1 to 898 E102G L105F F106I W107L K108G ...     898/900
(99 %)
36 diff
(96.0 %id)
BU149535 ductal carcinoma, cell line, Pancreas .e 335 to 1226 1 to 897 V113C V114R C115V V116C A117G ...     897/904
(99 %)
16 diff
(98.3 %id)
CR625103 Placenta Cot 25-normalized .e 336 to 1304 1 to 969 exact     969/969
(100 %)
0 diff
(100 %id)
AL548846 placenta, Placenta Cot 25-normalized .e 336 to 958 1 to 623   fully sequenced,   623/623
(100 %)
1 diff
(99.9 %id)
CR608719 fetal liver .e 337 to 1329 1 to 993 exact     993/993
(100 %)
0 diff
(100 %id)
BX422704 fetal liver, Liver .e 337 to 1326 1 to 994 G9W L10P Q12P R14P H15P ...     994/994
(100 %)
30 diff
(97.0 %id)
TI_57192821   .e 337 to 1100 56 to 821       766/949
(80 %)
13 diff
(98.7 %id)
CN342752 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 338 to 668 1 to 331       331/331
(100 %)
0 diff
(100 %id)
BU169737 epithelioid carcinoma, Pancreas .e 340 to 1206 1 to 871 K82E E110K A121X C122W L123P ...     871/905
(96 %)
24 diff
(97.4 %id)
BE905641 epithelioid carcinoma, Pancreas .e 341 to 1161 1 to 815       815/837
(97 %)
33 diff
(96.1 %id)
BE906475 epithelioid carcinoma, Pancreas .e 341 to 1010 1 to 670       670/673
(99 %)
3 diff
(99.6 %id)
CA777260 Pancreas, Purified pancreatic islet .e 341 to 941 1 to 601   fully sequenced,   601/601
(100 %)
0 diff
(100 %id)
BE271726 adenocarcinoma cell line, ovary .e 342 to 935 1 to 594       594/594
(100 %)
0 diff
(100 %id)
BE744397 adenocarcinoma cell line, ovary .e 342 to 1149 1 to 805       805/917
(87 %)
18 diff
(98.1 %id)
BE796466 lung, small cell carcinoma .e 342 to 1204 1 to 855 F54X V80C E81R K82E I83N ...     855/1025
(83 %)
26 diff
(97.5 %id)
BE792677 lung, small cell carcinoma .e 343 to 1117 1 to 769       769/781
(98 %)
8 diff
(99.0 %id)
BG333441 large cell carcinoma, lung .e 343 to 1229 1 to 874 T70I T71P P72L E73S C74V ...     872/885
(98 %)
22 diff
(97.6 %id)
BQ049796 lymph, lymphoma, cell line .e 345 to 1207 12 to 884 K108E C122W Q128P D132E R133Q ...     873/1089
(80 %)
26 diff
(97.7 %id)
CR618181 Placenta Cot 25-normalized .e 348 to 1328 1 to 981 exact     981/981
(100 %)
0 diff
(100 %id)
CR620505 HeLa cells Cot 25-normalized .e 348 to 1319 1 to 972 exact     972/972
(100 %)
0 diff
(100 %id)
AL556643 placenta .e 348 to 1319 1 to 970 F93X V116F R129P E137G V139G ... fully sequenced,   970/970
(100 %)
22 diff
(97.8 %id)
TI_57218975   .e 348 to 1187 28 to 873 A3L P8A G9W L10P Q12P ...     845/873
(96 %)
38 diff
(95.7 %id)
TI_44165606   .e 351 to 961 148 to 757       610/757
(80 %)
10 diff
(98.7 %id)
BC000996 Cervix, carcinoma .e 352 to 1572 1 to 1221 exact tiling clone, available from MGC, AAA   1221/1221
(100 %)
0 diff
(100 %id)
BE383840 melanotic melanoma, skin .e 353 to 1160 1 to 808       808/808
(100 %)
13 diff
(98.4 %id)
BQ053240 blood, natural killer cells, cell line .e 353 to 1330 1 to 986 L118P I119D F120L C122W L123S ...     986/1060
(93 %)
36 diff
(96.7 %id)
BM312488 Pancreas, Purified pancreatic islet .e 355 to 806 1 to 452       452/453
(99 %)
0 diff
(100 %id)
BE909039 epithelioid carcinoma, Pancreas .e 356 to 900 1 to 545       545/545
(100 %)
0 diff
(100 %id)
BG472243 eye, retinoblastoma .e 357 to 1272 1 to 920 F54L V55W V56*     920/922
(99 %)
34 diff
(96.4 %id)
BC001667 Lung, small cell carcinoma .e 358 to 1331 10 to 983 exact available from MGC, AAA   974/974
(100 %)
0 diff
(100 %id)
BC019277 Lung, small cell carcinoma .e 358 to 1331 1 to 974 exact available from MGC, AAA   974/974
(100 %)
0 diff
(100 %id)
CA392118 eye, RPE/choroid .e 358 to 851 1 to 494   fully sequenced,   494/494
(100 %)
0 diff
(100 %id)
CN342751 embryonic stem cells, DMSO-treated H9 cellline .e 359 to 1044 1 to 686       686/686
(100 %)
0 diff
(100 %id)
BE513862 Burkitt lymphoma, lymph .e 360 to 724 1 to 365       365/365
(100 %)
0 diff
(100 %id)
BQ417123 Pancreas, Purified pancreatic islet .e 371 to 872 1 to 502   fully sequenced,   502/502
(100 %)
0 diff
(100 %id)
BE267959 Burkitt lymphoma, lymph .e 375 to 1084 1 to 702       704/708
(99 %)
15 diff
(97.9 %id)
BE396510 Burkitt lymphoma, lymph .e 375 to 1040 1 to 665       665/665
(100 %)
1 diff
(99.9 %id)
BE561212 Burkitt lymphoma, lymph .e 375 to 1144 1 to 768       768/976
(78 %)
7 diff
(99.3 %id)
BE792140 lung, small cell carcinoma .e 384 to 1239 1 to 852 A135G K138Q     852/931
(91 %)
14 diff
(98.5 %id)
BU859923 adenocarcinoma, cell line, breast .e 386 to 1300 1 to 928 exact     928/931
(99 %)
22 diff
(97.7 %id)
CN342764 embryonic stem cells, DMSO-treated H9 cellline .e 387 to 808 1 to 422       422/422
(100 %)
0 diff
(100 %id)
CT004481 T-Lymphocytes .e 393 to 1043 1 to 651       651/653
(99 %)
1 diff
(99.9 %id)
CR983325 T-Lymphocytes .e 393 to 1172 1 to 784 F106I W107L K108E F109V E110R ...     784/784
(100 %)
4 diff
(99.5 %id)
CR995148 T-Lymphocytes .e 393 to 1060 1 to 669       669/670
(99 %)
2 diff
(99.8 %id)
CR984099 T-Lymphocytes .e 393 to 1049 1 to 657       657/659
(99 %)
1 diff
(99.9 %id)
CR981824 T-Lymphocytes .e 393 to 1065 1 to 673       673/673
(100 %)
0 diff
(100 %id)
CR995545 T-Lymphocytes .e 393 to 736 1 to 344       344/344
(100 %)
0 diff
(100 %id)
TI_149301512   .e 393 to 1331 1003 to 78 G6E AAA   926/956
(96 %)
25 diff
(97.4 %id)
BX436245 fetal liver, Liver .e 418 to 1329 911 to 1 exact     911/916
(99 %)
33 diff
(96.4 %id)
AF131797   .e 420 to 1572 1 to 1153 exact AAA   1153/1153
(100 %)
0 diff
(100 %id)
EB387373 eye, optic nerve .e 422 to 1306 1 to 885 exact     885/885
(100 %)
0 diff
(100 %id)
CB160321 Liver .e 433 to 988 1 to 556       556/556
(100 %)
0 diff
(100 %id)
CA942890 Pancreas, Purified pancreatic islet .e 450 to 958 1 to 509   fully sequenced,   509/509
(100 %)
0 diff
(100 %id)
TI_154051962   .e 453 to 1331 958 to 84 exact AAA   875/967
(90 %)
22 diff
(97.8 %id)
BU173893 melanotic melanoma, cell line, skin .e 463 to 1330 1 to 871 exact     871/873
(99 %)
9 diff
(99.0 %id)
BQ878351 epidermoid carcinoma, cell line, salivary gland .e 463 to 1330 1 to 877 exact AAA   877/877
(100 %)
16 diff
(98.2 %id)
TI_59391373   .e 515 to 1300 87 to 870 I143S E144S S145P I146Y     784/784
(100 %)
5 diff
(99.4 %id)
BU685121 lung, Primary Lung Cystic Fibrosis EpithelialCells .e 527 to 1331 821 to 19 G6E AAA   803/803
(100 %)
6 diff
(99.3 %id)
BQ051606 blood, natural killer cells, cell line .e 530 to 1331 13 to 813 exact AAA   801/813
(98 %)
4 diff
(99.6 %id)
CN342750 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 537 to 808 1 to 272       272/272
(100 %)
0 diff
(100 %id)
TI_149301900   .e 537 to 1330 873 to 90 Q12P R14P H15P L16P C17L ... AAA   784/914
(85 %)
15 diff
(98.4 %id)
TI_149308924   .e 537 to 1346 886 to 87 exact AAA   800/947
(84 %)
15 diff
(98.5 %id)
TI_149311219   .e 537 to 1331 868 to 85 exact AAA   784/966
(81 %)
11 diff
(98.9 %id)
BM852355 Ascites, stomach .e 548 to 1047 1 to 500       500/500
(100 %)
0 diff
(100 %id)
BM696188 eye, human retina .e 559 to 875 1 to 317   fully sequenced,   317/317
(100 %)
0 diff
(100 %id)
TI_149297138   .e 577 to 1330 834 to 83 exact AAA   752/929
(80 %)
3 diff
(99.7 %id)
TI_154103702   .e 594 to 1331 833 to 107 L2G A3G G4L A5P G6F ... AAA   727/781
(93 %)
48 diff
(93.9 %id)
CD368489 Alveolar Macrophage, lung .e 607 to 1331 743 to 19 exact AAA   725/725
(100 %)
1 diff
(99.9 %id)
BI093614 cervix .e 622 to 1573 1 to 967 G13A R14A H15T L16S C17A ...     967/969
(99 %)
23 diff
(97.7 %id)
BQ181335 Knee, Osteoarthritic Cartilage .e 626 to 1331 724 to 19 exact AAA   706/706
(100 %)
2 diff
(99.8 %id)
BM907634 large cell carcinoma, lung .e 629 to 1331 761 to 55 A5P P8L T24P L27F V34L ... AAA Submitted on the opposite strand 707/1013
(69 %)
65 diff
(93.6 %id)
BU689274 lung .e 629 to 1331 719 to 19 exact AAA   701/702
(99 %)
2 diff
(99.8 %id)
AL524630 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .e 631 to 1331 22 to 722 exact fully sequenced,   701/722
(97 %)
10 diff
(98.7 %id)
BM982259 lung, Primary Lung Cystic Fibrosis EpithelialCells .e 633 to 1330 716 to 19 exact AAA   698/698
(100 %)
0 diff
(100 %id)
BM768551 stomach .e 640 to 1119 1 to 480       480/480
(100 %)
0 diff
(100 %id)
BM768580 stomach .e 640 to 1309 1 to 670 exact     670/670
(100 %)
0 diff
(100 %id)
BM769867 stomach .e 640 to 1259 1 to 620 exact     620/620
(100 %)
0 diff
(100 %id)
BF219907 lung, small cell carcinoma .e 644 to 1276 633 to 1 exact     633/633
(100 %)
4 diff
(99.4 %id)
TI_154102421   .e 645 to 1323 743 to 78 L2V A3R G6C R7A P8F ... AAA   667/789
(84 %)
27 diff
(96.6 %id)
BM828283 Ascites, stomach .e 646 to 1181 1 to 536 exact     536/536
(100 %)
0 diff
(100 %id)
TI_57182102   .e 648 to 1330 24 to 705 G13A R14A H15T L16S C17A ...     682/705
(96 %)
6 diff
(99.2 %id)
BE719625 head_neck .e 649 to 896 257 to 11       247/288
(85 %)
0 diff
(100 %id)
FN098154 breast carcinoma .e 650 to 724 1 to 75       75/75
(100 %)
3 diff
(96.0 %id)
BU687367 lung .e 654 to 1346 710 to 19 exact AAA   692/692
(100 %)
1 diff
(99.9 %id)
BU624502 cell lines, Enchondroma .e 654 to 1339 704 to 19 exact AAA   686/686
(100 %)
0 diff
(100 %id)
BM709848 eye, optic nerve .e 675 to 958 1 to 284   fully sequenced,   284/284
(100 %)
0 diff
(100 %id)
BM887740 eye .e 698 to 1182 1 to 485 exact     485/485
(100 %)
0 diff
(100 %id)
BM702181 eye, optic nerve .e 699 to 1330 1 to 631 exact fully sequenced,   631/631
(100 %)
4 diff
(99.4 %id)
BE621619 epithelioid carcinoma, Pancreas .e 722 to 1291 573 to 1 K89X R90E N91K E92*     573/573
(100 %)
3 diff
(99.5 %id)
BE621366 epithelioid carcinoma, Pancreas .e 723 to 1331 1 to 609 G13A R14A H15T L16S C17A ...     609/611
(99 %)
5 diff
(99.2 %id)
TI_1948097964   .e 723 to 1163 125 to 566       442/743
(59 %)
12 diff
(98.4 %id)
BM312894 Pancreas, Purified pancreatic islet .e 724 to 1330 607 to 1 P8X     607/607
(100 %)
0 diff
(100 %id)
BT007285   .e 724 to 1164 1 to 441 exact     441/441
(100 %)
0 diff
(100 %id)
CR456985   .e 724 to 1163 1 to 440       440/441
(99 %)
2 diff
(99.6 %id)
EL947630 eyeball .e 763 to 989 21 to 248       228/248
(91 %)
7 diff
(97.2 %id)
BG314951   .e 772 to 1075 307 to 4       304/307
(99 %)
4 diff
(98.7 %id)
BQ027177 lung, Metastatic Chondrosarcoma .e 777 to 1331 573 to 19   AAA   555/555
(100 %)
0 diff
(100 %id)
BU631724 cell lines, Chondrosarcoma .e 777 to 1331 572 to 18   AAA   555/555
(100 %)
0 diff
(100 %id)
BM996150 Chondrosarcoma, Left Pubic Bone .e 778 to 1332 573 to 19   AAA   555/555
(100 %)
0 diff
(100 %id)
BQ019234 lung, Metastatic Chondrosarcoma .e 778 to 1331 572 to 19   AAA   554/554
(100 %)
0 diff
(100 %id)
BM711875 eye, human retina .e 807 to 1309 1 to 502   fully sequenced,   502/502
(100 %)
5 diff
(99.1 %id)
BQ003099 Chondrosarcoma, Left Pelvis .e 810 to 1332 541 to 19   AAA   523/523
(100 %)
0 diff
(100 %id)
AW248680 lung, small cell carcinoma .e 811 to 1331 531 to 11   AAA   521/521
(100 %)
0 diff
(100 %id)
BQ416817 Pancreas, Purified pancreatic islet .e 814 to 1334 522 to 2   fully sequenced,   521/522
(99 %)
0 diff
(100 %id)
BM664466 eye, human retina .e 814 to 1330 535 to 19   fully sequenced, AAA   517/517
(100 %)
0 diff
(100 %id)
BM353069 Pancreas, Purified pancreatic islet .e 820 to 1330 511 to 1       511/511
(100 %)
0 diff
(100 %id)
CA392117 eye, RPE/choroid .e 822 to 1331 533 to 24   fully sequenced, AAA   510/510
(100 %)
0 diff
(100 %id)
AI081515 Kidney .e 833 to 1330 498 to 1       498/498
(100 %)
0 diff
(100 %id)
CK822234 Pancreas, Purified pancreatic islet .e 846 to 1331 506 to 14   AAA Submitted on the opposite strand 493/528
(93 %)
18 diff
(96.6 %id)
DB576014 hypothalamus .e 847 to 1330 1 to 484     Submitted on the opposite strand 484/485
(99 %)
3 diff
(99.4 %id)
CN342761 embryonic stem cells, DMSO-treated H9 cellline .e 848 to 1292 1 to 445       445/445
(100 %)
0 diff
(100 %id)
AA701486 liver and spleen .e 849 to 1331 482 to 1       482/482
(100 %)
0 diff
(100 %id)
TI_154049801   .e 849 to 1332 571 to 91   AAA   481/573
(83 %)
5 diff
(99.2 %id)
DB551301 hippocampus .e 855 to 1330 1 to 476     Submitted on the opposite strand 476/477
(99 %)
1 diff
(99.8 %id)
AI568647 anaplastic oligodendroglioma, brain .e 855 to 1332 478 to 1       478/478
(100 %)
0 diff
(100 %id)
AI718057 aorta .e 859 to 1323 465 to 1       465/465
(100 %)
0 diff
(100 %id)
AW151873 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .e 862 to 1151 295 to 6       290/295
(98 %)
18 diff
(93.9 %id)
AA593316 Kidney, kidney tumor .e 864 to 1330 466 to 1       466/466
(100 %)
0 diff
(100 %id)
CN342763 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 869 to 1307 1 to 439       439/439
(100 %)
0 diff
(100 %id)
TI_149281359   .e 873 to 1331 555 to 97   AAA   459/672
(68 %)
5 diff
(99.3 %id)
TI_149284195   .e 873 to 1331 556 to 98   AAA   459/801
(57 %)
5 diff
(99.4 %id)
DB567180 hypothalamus .e 874 to 1330 1 to 457     Submitted on the opposite strand 457/457
(100 %)
2 diff
(99.6 %id)
AW015199   .e 878 to 1331 471 to 18   AAA   454/454
(100 %)
0 diff
(100 %id)
AI149434 placenta .e 879 to 1331 468 to 16   AAA   453/453
(100 %)
0 diff
(100 %id)
AI384079 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 879 to 1331 453 to 1       453/453
(100 %)
0 diff
(100 %id)
AA837073 germinal center B cell .e 888 to 1331 477 to 34   AAA   444/444
(100 %)
0 diff
(100 %id)
AL573253 placenta, Placenta Cot 25-normalized .e 897 to 1304 407 to 1   fully sequenced,   407/407
(100 %)
1 diff
(99.8 %id)
AL578857 placenta .e 897 to 1304 419 to 12   fully sequenced,   408/419
(97 %)
0 diff
(100 %id)
AL579032 placenta .e 897 to 1297 400 to 1   fully sequenced,   400/400
(100 %)
3 diff
(99.3 %id)
AI032032 liver and spleen .e 897 to 1330 434 to 1       434/434
(100 %)
0 diff
(100 %id)
BF569123 epithelioid carcinoma cell line, Pancreas .e 897 to 1279 387 to 1   fully sequenced,   387/387
(100 %)
0 diff
(100 %id)
CA776973 Pancreas, Purified pancreatic islet .e 897 to 1331 436 to 2   fully sequenced,   435/436
(99 %)
0 diff
(100 %id)
CA942650 Pancreas, Purified pancreatic islet .e 897 to 1331 437 to 3   fully sequenced,   435/437
(99 %)
0 diff
(100 %id)
BM665685 eye, human retina .e 897 to 1331 454 to 19   fully sequenced, AAA   436/436
(100 %)
0 diff
(100 %id)
BM664875 eye, optic nerve .e 897 to 1331 453 to 19   fully sequenced, AAA   435/435
(100 %)
0 diff
(100 %id)
BU734208 eye, optic nerve .e 897 to 1331 453 to 19   fully sequenced, AAA   435/435
(100 %)
0 diff
(100 %id)
AI186587 placenta .e 898 to 1143 246 to 1       246/246
(100 %)
0 diff
(100 %id)
AI560154 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .e 898 to 1332 451 to 17   AAA   435/435
(100 %)
0 diff
(100 %id)
AI479017 B-cell, chronic lymphotic leukemia .e 899 to 1331 454 to 22   AAA   433/433
(100 %)
0 diff
(100 %id)
BI049156 uterus .e 903 to 1122 220 to 1       220/229
(96 %)
5 diff
(97.9 %id)
BI048785 uterus .e 908 to 1122 216 to 1       216/232
(93 %)
17 diff
(92.7 %id)
AI858753 anaplastic oligodendroglioma, brain .e 909 to 1331 423 to 1       423/423
(100 %)
0 diff
(100 %id)
AI083503 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 914 to 1331 418 to 1       418/418
(100 %)
0 diff
(100 %id)
AI366814   .e 917 to 1330 433 to 20   AAA   414/414
(100 %)
0 diff
(100 %id)
AI570826 adenocarcinoma, Pancreas .e 918 to 1331 414 to 1       414/414
(100 %)
0 diff
(100 %id)
AI333776 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 921 to 1331 411 to 1       411/411
(100 %)
0 diff
(100 %id)
BM673662 eye, eye anterior segment .e 926 to 1331 420 to 15   AAA   406/406
(100 %)
0 diff
(100 %id)
AW969169   .e 949 to 1330 382 to 1     Submitted on the opposite strand 382/382
(100 %)
28 diff
(92.7 %id)
AI358982 brain, glioblastoma (pooled) .e 950 to 1323 374 to 1       374/374
(100 %)
0 diff
(100 %id)
BQ330677 lung_tumor .e 955 to 1122 1 to 168       168/168
(100 %)
0 diff
(100 %id)
BQ016321 lung, Metastatic Chondrosarcoma .e 966 to 1572 623 to 17   AAA   607/619
(98 %)
2 diff
(99.7 %id)
GD136313   .e 973 to 1331 1 to 359   AAA   359/359
(100 %)
6 diff
(98.4 %id)
TI_57242458   .e 976 to 1572 69 to 664   AAA   596/664
(89 %)
8 diff
(98.8 %id)
AL524629 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .e 977 to 1314 338 to 1   fully sequenced,   338/338
(100 %)
2 diff
(99.5 %id)
GD158355   .e 978 to 1330 6 to 358   AAA   353/358
(98 %)
6 diff
(98.4 %id)
AI380000 B-cell, chronic lymphotic leukemia .e 980 to 1330 351 to 1       351/351
(100 %)
0 diff
(100 %id)
BE832658 ovary .e 991 to 1363 378 to 6       373/378
(98 %)
10 diff
(97.4 %id)
BU607930 Human Lung Epithelial cells, lung .e 992 to 1331 358 to 19   AAA   340/345
(98 %)
2 diff
(99.5 %id)
BI049125 uterus .e 1001 to 1122 123 to 1       123/133
(92 %)
5 diff
(96.3 %id)
CV371189 uterus .e 1007 to 1122 118 to 1     Submitted on the opposite strand 118/142
(83 %)
7 diff
(95.1 %id)
AA555223 colon, tumor .e 1008 to 1330 322 to 1       322/322
(100 %)
0 diff
(100 %id)
AW614545 Kidney .e 1010 to 1331 322 to 1       322/322
(100 %)
0 diff
(100 %id)
AA722795 heart .e 1026 to 1331 306 to 1       306/306
(100 %)
0 diff
(100 %id)
AI147761 brain, glioblastoma (pooled) .e 1073 to 1574 502 to 1       502/502
(100 %)
0 diff
(100 %id)
AA583766 larynx .e 1095 to 1331 237 to 1       237/237
(100 %)
0 diff
(100 %id)
BE857795 ovary, papillary serous carcinoma .e 1098 to 1194 1 to 97       97/97
(100 %)
8 diff
(91.8 %id)
AI344058 bronchioalveolar carcinoma, lung .e 1099 to 1245 14 to 160     Submitted on the opposite strand 147/160
(91 %)
6 diff
(96.3 %id)
AI377610 bronchioalveolar carcinoma, lung .e 1099 to 1331 20 to 252   AAA Submitted on the opposite strand 233/252
(92 %)
6 diff
(97.7 %id)
EC536249 Prostate .e 1107 to 1209 98 to 1       98/98
(100 %)
5 diff
(94.9 %id)
AI057354 liver and spleen .e 1107 to 1331 238 to 14   AAA   225/225
(100 %)
0 diff
(100 %id)
BQ377687 uterus .e 1123 to 1240 121 to 2       120/126
(95 %)
0 diff
(100 %id)
AI963149 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .e 1126 to 1330 219 to 15   AAA   205/205
(100 %)
0 diff
(100 %id)
EC571724 Prostate .e 1129 to 1229 1 to 101       101/101
(100 %)
0 diff
(100 %id)
BU617222 Bone, Subchondral Bone .e 1132 to 1332 217 to 17   AAA   201/201
(100 %)
0 diff
(100 %id)
BG957803 colon .e 1139 to 1265 146 to 22       125/146
(85 %)
0 diff
(100 %id)
BI048784 uterus .e 1139 to 1265 127 to 3       125/127
(98 %)
0 diff
(100 %id)
BI049151 uterus .e 1139 to 1265 128 to 3       126/128
(98 %)
0 diff
(100 %id)
BI049155 uterus .e 1139 to 1265 141 to 16       126/141
(89 %)
0 diff
(100 %id)
AA683473 uterus .e 1145 to 1323 179 to 1       179/179
(100 %)
0 diff
(100 %id)
T30169 uterus .e 1148 to 1472 1 to 325       325/325
(100 %)
0 diff
(100 %id)
AW954170   .e 1149 to 1572 1 to 424   AAA   424/424
(100 %)
0 diff
(100 %id)
AI521993 Kidney .e 1149 to 1331 183 to 1       183/183
(100 %)
0 diff
(100 %id)
EC471897 Prostate .e 1151 to 1253 1 to 103       103/103
(100 %)
0 diff
(100 %id)
BU171665 melanotic melanoma, skin .e 1183 to 1335 1 to 153   AAA   153/153
(100 %)
0 diff
(100 %id)
AI090977 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 1188 to 1330 143 to 1       143/143
(100 %)
0 diff
(100 %id)
AA419574 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 1189 to 1330 142 to 2     Submitted on the opposite strand 141/142
(99 %)
0 diff
(100 %id)
AA630680 lung, lung carcinoma .e 1189 to 1490 302 to 1       302/302
(100 %)
0 diff
(100 %id)
AI024017 liver and spleen .e 1189 to 1330 142 to 1       142/142
(100 %)
0 diff
(100 %id)
AA902945 leiomyosarcoma, soft tissue .e 1190 to 1331 152 to 11   AAA   142/142
(100 %)
0 diff
(100 %id)
AI040681 liver and spleen .e 1190 to 1330 141 to 1       141/141
(100 %)
0 diff
(100 %id)
BF980420 duodenal adenocarcinoma, cell line, small intestine .e 1208 to 1570 1 to 363   AAA   363/363
(100 %)
0 diff
(100 %id)
AI581804 colon .e 1212 to 1323 112 to 1       112/112
(100 %)
0 diff
(100 %id)
EC541833 Prostate .e 1223 to 1326 109 to 7       103/109
(94 %)
0 diff
(100 %id)
EC523981 Prostate .e 1236 to 1328 1 to 93       93/99
(93 %)
3 diff
(97.0 %id)
AI431464 lymph node, lymphoma, follicular mixed small and largecell .e 1238 to 1331 101 to 8       94/101
(93 %)
0 diff
(100 %id)
AI860163 Kidney .e 1274 to 1572 299 to 1       299/299
(100 %)
0 diff
(100 %id)
H54685 liver and spleen .e 1342 to 1539 198 to 1       198/198
(100 %)
0 diff
(100 %id)
DN912171   .e 1477 to 1896 1 to 420       420/423
(99 %)
27 diff
(93.7 %id)
AA468103   .e 1484 to 1654 33 to 203       171/203
(84 %)
6 diff
(97.1 %id)
EC484791 Prostate .e 1485 to 1601 1 to 116       116/116
(100 %)
5 diff
(95.7 %id)
EC499266 Prostate .e 1486 to 1601 1 to 115       115/115
(100 %)
3 diff
(97.4 %id)
EC500056 Prostate .e 1486 to 1601 1 to 116       116/116
(100 %)
2 diff
(98.3 %id)
AA228285   .e 1486 to 1866 1 to 379       379/379
(100 %)
2 diff
(99.5 %id)
FN134105 breast carcinoma .e 1488 to 1572 1 to 85       85/85
(100 %)
1 diff
(98.9 %id)
EC515122 Prostate .e 1490 to 1600 1 to 113       113/115
(98 %)
5 diff
(95.7 %id)
W22355 eye, retina .e 1497 to 1973 1 to 477   tiling clone,   477/690
(69 %)
11 diff
(98.5 %id)
FN092009 breast carcinoma .e 1738 to 1822 1 to 82       82/83
(98 %)
5 diff
(94.0 %id)
AW062306 breast .e 1777 to 1973 12 to 204       193/205
(94 %)
14 diff
(93.2 %id)
AI910061 breast .e 1783 to 1898 1 to 116       116/116
(100 %)
1 diff
(99.2 %id)
AW369860 breast .e 1783 to 1973 1 to 191   tiling clone,   191/192
(99 %)
1 diff
(99.5 %id)
FN062064 breast carcinoma .e 1789 to 1846 1 to 56       56/56
(100 %)
2 diff
(96.5 %id)
FN093130 breast carcinoma .e 1907 to 1972 1 to 65       65/65
(100 %)
1 diff
(98.5 %id)
BC004239 Uterus, endometrium adenocarcinoma .f 1 to 1040 1 to 1040 exact tiling clone, available from MGC, AAA   1040/1040
(100 %)
0 diff
(100 %id)
BE392820 endometrium, adenocarcinoma cell line, uterus .f 20 to 595 1 to 574       574/575
(99 %)
5 diff
(99.2 %id)
BG027674 Bone, osteosarcoma, cell line .f 152 to 909 1 to 748 S69Q A70L L71*     748/946
(79 %)
22 diff
(97.7 %id)
AI954083 normal epithelium, ovary .f 309 to 1039 733 to 8 exact     726/777
(93 %)
10 diff
(98.8 %id)
AA418929 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f 337 to 747 13 to 424   fully sequenced,   412/424
(97 %)
7 diff
(98.4 %id)
CR997721 T-Lymphocytes .f 358 to 762 103 to 507       405/507
(79 %)
6 diff
(98.9 %id)
AA418840 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f 686 to 1040 355 to 1   fully sequenced,   355/355
(100 %)
2 diff
(99.5 %id)
BM313128 Pancreas, Purified pancreatic islet .g 1 to 515 6 to 520 exact tiling clone,   520/520
(100 %)
0 diff
(100 %id)
BG495796 lung, mucoepidermoid carcinoma .h 1 to 707 1 to 718   tiling clone,   718/784
(91 %)
16 diff
(98.0 %id)
CR595312 Neuroblastoma Cot 10-normalized .h 16 to 1203 1 to 1188 exact     1188/1188
(100 %)
0 diff
(100 %id)
AL522366 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .h 16 to 858 1 to 843   fully sequenced,   843/843
(100 %)
3 diff
(99.7 %id)
BG341187 B-cells, primary B-cells from tonsils (cell line) .h 16 to 696 1 to 683       683/684
(99 %)
14 diff
(98.0 %id)
BG342119 B-cells, primary B-cells from tonsils (cell line) .h 16 to 752 1 to 734       734/907
(80 %)
25 diff
(97.3 %id)
BQ064043 lymph, lymphoma, cell line .h 18 to 766 1 to 766       766/1130
(67 %)
24 diff
(97.9 %id)
DA897764 skeletal muscle .h 19 to 588 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
W37396 parathyroid gland, parathyroid tumor .h 20 to 429 1 to 419       419/423
(99 %)
31 diff
(92.7 %id)
DT216784 brain .h 90 to 778 1 to 688       688/688
(100 %)
5 diff
(99.3 %id)
AF151056 umbilical cord blood .h 139 to 1231 1 to 1087 exact tiling clone, AAA   1087/1087
(100 %)
11 diff
(99.0 %id)
BP331571 rectum .h 230 to 819 1 to 593       593/593
(100 %)
3 diff
(99.5 %id)
AW806582 stomach .h 595 to 971 376 to 1       376/376
(100 %)
8 diff
(97.9 %id)
AW070310 pooled .h 599 to 1084 1 to 486 exact   Submitted on the opposite strand 486/486
(100 %)
0 diff
(100 %id)
CA414493 Chondrosarcoma Grade II, Left Pelvis .h 627 to 1231 622 to 19 L17X F25X C45F AAA   604/604
(100 %)
2 diff
(99.7 %id)
BI521151 pooled pancreas and spleen .h 680 to 1230 1 to 548 F25L V26W V27* AAA   548/548
(100 %)
3 diff
(99.5 %id)
BI522158 pooled pancreas and spleen .h 680 to 1165 496 to 12 A88G     485/496
(97 %)
1 diff
(99.8 %id)
CV026357 mixed .h 711 to 1071 1 to 361 exact     361/515
(70 %)
5 diff
(99.1 %id)
BE348436 carcinoid, lung .h 713 to 1234 529 to 8   tiling clone,   522/529
(98 %)
0 diff
(100 %id)
BM312839 Pancreas, Purified pancreatic islet .h 734 to 1229 496 to 1       496/496
(100 %)
2 diff
(99.6 %id)
W37397 parathyroid gland, parathyroid tumor .h 738 to 1231 502 to 5       498/506
(98 %)
5 diff
(99.1 %id)
AL522365 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .h 797 to 1203 406 to 1   fully sequenced,   406/406
(100 %)
5 diff
(98.8 %id)
CV570327 cornea, eye .i 1 to 368 1 to 368 A85V tiling clone,   368/368
(100 %)
1 diff
(99.8 %id)
CN342753 embryonic stem cells, DMSO-treated H9 cellline .j 1 to 659 7 to 665   tiling clone,   659/665
(99 %)
6 diff
(99.1 %id)
BI226567 Burkitt lymphoma, lymph .j 7 to 541 1 to 534       534/534
(100 %)
6 diff
(98.9 %id)
BE561350 Burkitt lymphoma, lymph .j 28 to 781 1 to 753 C91V G92V S93A R94E R95E ... tiling clone,   753/754
(99 %)
3 diff
(99.7 %id)
AK128675 uterus .k 1 to 2122 2 to 2121 exact tiling clone, available from FLJ,   2121/2121
(100 %)
2 diff
(100.0 %id)
DB274265 uterus .k 1 to 478 2 to 480 V50C D51G I52Y E53R K55E ... capped   479/479
(100 %)
1 diff
(99.8 %id)
AW510375 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .k 1301 to 1804 502 to 1   tiling clone,   502/502
(100 %)
20 diff
(96.1 %id)
DB352087 uterus .k 1600 to 2120 523 to 3       521/523
(99 %)
0 diff
(100 %id)
CN396084 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .l 1 to 747 1 to 747 A55G tiling clone,   747/747
(100 %)
1 diff
(99.9 %id)
BM045896 carcinoma, cell line, Prostate .l 4 to 647 1 to 648       648/650
(99 %)
7 diff
(99.0 %id)
AI906870 breast .m 1 to 438 12 to 449 exact tiling clone,   438/458
(95 %)
3 diff
(99.4 %id)
BI116017 lung, small cell carcinoma .n 1 to 897 1 to 913 exact tiling clone,   913/987
(92 %)
26 diff
(97.4 %id)
CN342755 embryonic stem cells, cell lines H1, H7, andH9 .n 9 to 597 1 to 588 exact     588/588
(100 %)
2 diff
(99.7 %id)
BG026796 Bone, osteosarcoma, cell line .n 10 to 774 1 to 763 exact     763/1039
(73 %)
32 diff
(97.0 %id)
BI199677 brain, neuroblastoma .n 120 to 831 1 to 720 exact     720/901
(79 %)
18 diff
(98.1 %id)
AW005522 anaplastic oligodendroglioma, brain .n 397 to 921 524 to 1 P8L Q12R G13A R14A H15T ... tiling clone,   524/524
(100 %)
2 diff
(99.7 %id)
AI950821 lung, two pooled squamous cell carcinomas .n 427 to 920 527 to 33   AAA   495/497
(99 %)
16 diff
(96.8 %id)
AA586725 larynx .n 478 to 921 443 to 2       442/447
(98 %)
0 diff
(100 %id)
AW609562 stomach .p-u 1 to 531 7 to 538   tiling clone,   532/546
(97 %)
6 diff
(99.0 %id)
TI_159711950   .p-u 13 to 601 591 to 1 C10S S33Y L52M     591/969
(60 %)
26 diff
(97.4 %id)
AW609561 stomach .p-u 20 to 531 7 to 518       512/532
(96 %)
11 diff
(98.0 %id)
BI491174 cochlea, ear .p-u 37 to 643 637 to 31 exact tiling clone, AAA   607/613
(99 %)
2 diff
(99.7 %id)
AW020142 cochlea, ear .p-u 37 to 539 8 to 511       504/511
(98 %)
10 diff
(98.1 %id)
AI193431 lung .p-u 271 to 643 379 to 6 I3X tiling clone,   374/379
(98 %)
0 diff
(100 %id)
BM680122 eye, fetal eye Gene RAB13andJTB, variant not shown       fully sequenced, AAA This clone was ignored    
BM724887 eye, fetal eye Gene RAB13andJTB, variant not shown       fully sequenced, This clone was ignored    
BM479107 duodenal adenocarcinoma, cell line, small intestine Gene RAB13andJTB, variant not shown              
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o-u, .p-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI